RxDoctor Payments Data

Daniel Ogata

Optometrist · Tigard, ORNPI 1720331549

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,354 of the $3,528 with a category attached, or 66.7%. Johnson & Johnson Vision Care, Inc. accounts for 71.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $2,408 and has fallen 94.2% since, to $141 in 2025. Among optometrist clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,528in general payments, 2019–2025

Across 46 payments — averaging $76.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$3K
  • Coopervision Inc.$469
  • Alcon$329
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$159
  • Sight Sciences, Inc.$31
  • Bausch & Lomb Americas Inc.$18

What the payments were for

  • Consulting fees$2,35467%
  • Food & beverage$1,17433%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,528 in reported general payments places this provider in the 90th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon

Medicare billing

Part B allowed, 2024
$11,492
Medicare patients
58
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost47$191

Paid to pharmacies, not to this prescriber.

Other optometrist in Tigard

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →